Journal article · 2018 · Open access

Validation of psychometric properties and development of response criteria for the psoriasis symptoms and signs diary (PSSD): results from a phase 3 clinical trial

April Wang Armstrong, L. Puig, Richard G B Langley, Tsen‐Fang Tsai, Michael Song, Yasmine S. Wasfi, Jingzhi Jiang, Shu Li, Chenglong Han

Journal of Dermatological Treatment, 30(1), 27–34 · Published 24 September 2018 · DOI 10.1080/09546634.2017.1364694

Open full textView at the publisherCite this paper

In brief

“Validation of psychometric properties and development of response criteria for the psoriasis symptoms and signs diary (PSSD): results from a phase 3 clinical trial” is a 2018 journal article by April Wang Armstrong and 8 co-authors, published in Journal of Dermatological Treatment. OpenAlex counts 37 citations as of 22 November 2026. It is open access under a CC BY licence: the full text is free to read at Figshare.

Citations
37
Most cited in
2025 (7)
Field-weighted impact
1.15
References
12
Authors
9

Abstract

PURPOSE: The Psoriasis Symptoms and Signs Diary (PSSD) is a patient-reported instrument that assesses severity of six symptoms (itch, skin tightness, burning, stinging, and pain) and five signs (dryness, cracking, scaling, shedding/flaking, redness, and bleeding) of psoriasis. MATERIALS AND METHODS: PSSD symptoms and signs summary scores (range, 0-100) were derived based on individual item scores (0-10 [absent-worst imaginable]). Using Psoriasis Area and Severity Index [PASI], Investigator's Global Assessment [IGA] and Dermatology Life Quality Index [DLQI]) data from the NAVIGATE trial of patients with moderate-to-severe psoriasis, analyses were conducted to further validate the PSSD (7-day recall version) and establish criteria for clinically meaningful improvements (CMIs). RESULTS: Mean PSSD symptoms and signs summary scores were 50.6 and 60.7, respectively, at baseline, with no major floor (score of 0) or ceiling (maximum score) effects. PSSD scores and changes in PSSD scores were highly correlated with PASI, IGA, and DLQI scores (most Spearman's correlation r's ≥0.4, all p < .001). A 2-grade improvement in IGA or an improvement of 75%-<90% in PASI was associated with CMIs of ≥40-points in PSSD summary scores and ≥3-5-points in individual item scores. CONCLUSIONS: The PSSD possesses strong psychometric properties and is suitable for use as a measure of disease severity in clinical studies of patients with moderate-to-severe psoriasis.

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Armstrong, A. W., Puig, L., Langley, R. G. B., Tsai, T., Song, M., Wasfi, Y. S., Jiang, J., Li, S., & Han, C. (2018). Validation of psychometric properties and development of response criteria for the psoriasis symptoms and signs diary (PSSD): results from a phase 3 clinical trial. Journal of Dermatological Treatment, 30(1), 27–34. https://doi.org/10.1080/09546634.2017.1364694

MLA 9

Armstrong, April Wang, et al. “Validation of psychometric properties and development of response criteria for the psoriasis symptoms and signs diary (PSSD): results from a phase 3 clinical trial.” Journal of Dermatological Treatment, vol. 30, no. 1, 2018, pp. 27–34. https://doi.org/10.1080/09546634.2017.1364694.

Chicago

Armstrong, April Wang, L. Puig, Richard G B Langley, Tsen‐Fang Tsai, Michael Song, Yasmine S. Wasfi, Jingzhi Jiang, Shu Li, and Chenglong Han. 2018. “Validation of psychometric properties and development of response criteria for the psoriasis symptoms and signs diary (PSSD): results from a phase 3 clinical trial.” Journal of Dermatological Treatment 30 (1): 27–34. https://doi.org/10.1080/09546634.2017.1364694.

Harvard

Armstrong, A. W. et al. (2018) ‘Validation of psychometric properties and development of response criteria for the psoriasis symptoms and signs diary (PSSD): results from a phase 3 clinical trial’, Journal of Dermatological Treatment, 30(1), pp. 27–34. doi:10.1080/09546634.2017.1364694.

IEEE

A. W. Armstrong et al., “Validation of psychometric properties and development of response criteria for the psoriasis symptoms and signs diary (PSSD): results from a phase 3 clinical trial,” Journal of Dermatological Treatment, vol. 30, no. 1, pp. 27–34, 2018, doi: 10.1080/09546634.2017.1364694.

BibTeX

@article{armstrong2018validation,
  title     = {{Validation of psychometric properties and development of response criteria for the psoriasis symptoms and signs diary (PSSD): results from a phase 3 clinical trial}},
  author    = {Armstrong, April Wang and Puig, L. and Langley, Richard G B and Tsai, Tsen‐Fang and Song, Michael and Wasfi, Yasmine S. and Jiang, Jingzhi and Li, Shu and Han, Chenglong},
  journal   = {Journal of Dermatological Treatment},
  year      = {2018},
  volume    = {30},
  number    = {1},
  pages     = {27--34},
  doi       = {10.1080/09546634.2017.1364694},
  url       = {https://doi.org/10.1080/09546634.2017.1364694}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Citations by year

YearCitationsShare of the best year
201833
201966
202011
202122
202244
202355
202455
202577
202644

Its field-weighted citation impact is 1.15: it has been cited 1.15 times as often as the average work of the same field, type and year (1.00 is the world average).

Topic and keywords

Life Sciences › Immunology and Microbiology › Immunology › Psoriasis: Treatment and Pathogenesis

  • psoriasis
  • patient-reported outcomes
  • psychometric validation
  • disease severity assessment
  • clinically meaningful improvement
  • moderate-to-severe psoriasis
  • PASI
  • Investigator's Global Assessment

Work with this paper

Most-cited papers in Immunology and Microbiology

All highly cited Immunology and Microbiology papers

Questions about this paper

How do I cite this paper in APA style?

Armstrong, A. W., Puig, L., Langley, R. G. B., Tsai, T., Song, M., Wasfi, Y. S., Jiang, J., Li, S., & Han, C. (2018). Validation of psychometric properties and development of response criteria for the psoriasis symptoms and signs diary (PSSD): results from a phase 3 clinical trial. Journal of Dermatological Treatment, 30(1), 27–34. https://doi.org/10.1080/09546634.2017.1364694

How many times has this paper been cited?

37 times, according to OpenAlex on 22 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

Yes. It is open access at Figshare: sign in and open the full text from this page.

Who wrote this paper?

April Wang Armstrong, L. Puig, Richard G B Langley, Tsen‐Fang Tsai, Michael Song, Yasmine S. Wasfi, Jingzhi Jiang, Shu Li, Chenglong Han.

What is the DOI of this paper?

10.1080/09546634.2017.1364694, permanently at https://doi.org/10.1080/09546634.2017.1364694. Sign in and open it from this page.

Bibliographic data from OpenAlex (CC0), last checked 22 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.